inc headquart danver
lead provid medic devic design use
primarili use either cardiac catheter
lab cath lab intervent cardiologist
heart surgeri suit cardiovascular surgeon
patient receiv devic need
prophylact hemodynam support high-risk
angioplasti procedur experienc pre-shock
shock profound cardiogen shock
reason report
estim chang analysi sales/earn
battl nois reiter o/v rate
report in-lin quarter follow compani pre-
announc reiter previous reduc corpor
guidanc compani formal establish
guidanc clear heighten invest need take place
order educ center support clinic data compani
sale forc result drive util compani impella
offer face heighten nois must re-acceler
domest growth also success navig upcom
ipp rate review remain optimist compani abil
effect restor growth note take time
result forecast annual revenu growth versu
aid favor new product cadenc
increas train educ data simpli put
near-term remain challeng long-term growth potenti
share remain unchang recal price target impli
revenu multipl approxim
revis estim follow report fiscal
oper result revis revenu
earn estim reflect compani fy actual result
specif reduc former million revenu
estim million revis non-gaap earn
estim per share revis former
billion revenu non-gaap earn estim
million per share respect estim
chang summar tabl left
establish oper guidanc assign emphasi
lower bound annual revenu guidanc specif
compani expect annual report revenu growth
million million pre-cal consensu
million oper margin rang pre-
import disclosur analyst certif page report access current disclosur stephen
inc cover compani client may refer
fiscal summari review fiscal total revenu increas annual million pre-cal
consensu million impella product revenu grew modest million util increas
annual intern sale increas million driven europ japan yield
quarterli revenu million quarterli gross margin declin year year result
smartassist launch geograph mix total oper expens increas million research
develop expens increas million sell gener administr expens increas
million result report oper margin quarter earn
per share includ benefit compani shockwav invest rate
excess tax benefit relat stock compens exclud onetim item report adjust
earn per share pre-cal consensu per share
fiscal period impella util favor emerg indic versu protect
pci quarter furthermor new site result domest
hospit impella cp impella penetr impela penetr
impella rp penetr lastli fiscal oper period domest reorder rate
slightli exceed averag combin inventori held hospit impella cp unit
balanc sheet review fiscal oper period gener million oper cash flow
repres annual increas result exit fiscal oper period million
cash market secur debt yield net cash per share opinion favor
oper model character high cash flow gener combin cash rich balanc sheet untap
credit capac provid suffici financi latitud fund work capit need invest
oper initi pursu strateg opportun may aris via fund oper
capit deploy fiscal oper period bought back million stock compani
repurchas program conjunct call reiter organ growth initi remain main focu
capit deploy
valuat summari share current valu revenu versu compar peer trade
like multipl admittedli share still possess slight rel premium view merit base
compani larg exist effect monopoli busi model top tier gross oper
margin profil profit debt free cash rich balanc sheet
consolid statement incom
dollar thousand except per share data
product revenu
research develop
sell gener administr
total incom expens
fiscal period
fiscal period
incom continu oper tax
tax incom continu oper
compani report stephen inc estim
analyst primarili respons prepar content report certifi view express report
accur reflect analyst person view subject compani secur ii part analyst compens
directli indirectli relat specif recommend view express analyst report
